Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
8%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
BBH
27
HOLDINGS
21%
ALSO IN CANC
CANC
52
HOLDINGS
10%
ALSO IN BBH
SECTOR DRIFT (BBH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
BEIGENE LTD. SPONSORED ADR | 3.9% | 2.4% | 2.4% |
|
GILEAD SCIENCES INC | 12.2% | 1.8% | 1.8% |
|
AMGEN INC | 12.4% | 1.8% | 1.8% |
|
REGENERON PHARMACEUTICALS | 5.3% | 1.4% | 1.4% |
 |
ARGENX SE ADR | 4.9% | 1.1% | 1.1% |
BBH Overweight Relative to CANC
|
AMGEN INC | 10.7% |
|
GILEAD SCIENCES INC | 10.4% |
|
VERTEX PHARMACEUTICALS INC | 9.4% |
|
INSMED INC | 5.3% |
|
IQVIA HOLDINGS INC | 4.8% |
|
NATERA INC | 4.7% |
|
ALNYLAM PHARMACEUTICALS INC | 4.4% |
|
REGENERON PHARMACEUTICALS | 4.0% |
|
ARGENX SE ADR | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.5% |
BBH Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -7.0% |
|
ELI LILLY & CO | -5.4% |
|
BRIDGEBIO PHARMA, INC. | -4.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -3.9% |
|
NOVARTIS AG | -3.9% |
 |
ASTRAZENECA PLC | -3.9% |
 |
GENMAB A/S SPONSORED ADR | -3.9% |
|
ARCELLX, INC. | -3.9% |
|
NUVALENT, INC. CLASS A | -3.8% |
|
EXELIXIS INC | -2.9% |